ID   DDIT3_RAT               Reviewed;         168 AA.
AC   Q62857;
DT   13-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 136.
DE   RecName: Full=DNA damage-inducible transcript 3 protein;
DE            Short=DDIT-3;
DE   AltName: Full=C/EBP zeta;
DE   AltName: Full=C/EBP-homologous protein;
DE            Short=CHOP;
DE   AltName: Full=C/EBP-homologous protein 10;
DE            Short=CHOP-10;
DE   AltName: Full=CCAAT/enhancer-binding protein homologous protein;
DE   AltName: Full=Growth arrest and DNA-damage-inducible protein GADD153;
GN   Name=Ddit3; Synonyms=Chop, Chop10, Gadd153;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Jin K.L., Chen J., Simon R.P., Graham S.H.;
RL   Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Multifunctional transcription factor in ER stress response.
CC       Plays an essential role in the response to a wide variety of cell
CC       stresses and induces cell cycle arrest and apoptosis in response to ER
CC       stress. Plays a dual role both as an inhibitor of CCAAT/enhancer-
CC       binding protein (C/EBP) function and as an activator of other genes.
CC       Acts as a dominant-negative regulator of C/EBP-induced transcription:
CC       dimerizes with members of the C/EBP family, impairs their association
CC       with C/EBP binding sites in the promoter regions, and inhibits the
CC       expression of C/EBP regulated genes. Positively regulates the
CC       transcription of TRIB3, IL6, IL8, IL23, TNFRSF10B/DR5, PPP1R15A/GADD34,
CC       BBC3/PUMA, BCL2L11/BIM and ERO1L. Negatively regulates; expression of
CC       BCL2 and MYOD1, ATF4-dependent transcriptional activation of asparagine
CC       synthetase (ASNS), CEBPA-dependent transcriptional activation of
CC       hepcidin (HAMP) and CEBPB-mediated expression of peroxisome
CC       proliferator-activated receptor gamma (PPARG). Inhibits the canonical
CC       Wnt signaling pathway by binding to TCF7L2/TCF4, impairing its DNA-
CC       binding properties and repressing its transcriptional activity. Plays a
CC       regulatory role in the inflammatory response through the induction of
CC       caspase-11 (CASP4/CASP11) which induces the activation of caspase-1
CC       (CASP1) and both these caspases increase the activation of pro-IL1B to
CC       mature IL1B which is involved in the inflammatory response. Acts as a
CC       major regulator of postnatal neovascularization through regulation of
CC       endothelial nitric oxide synthase (NOS3)-related signaling (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer (By similarity). Interacts with TCF7L2/TCF4,
CC       EP300/P300, HDAC1, HDAC5 and HDAC6. Interacts with TRIB3 which blocks
CC       its association with EP300/P300. Interacts with FOXO3, CEBPB and ATF4
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000255|PROSITE-ProRule:PRU00978}. Note=Present in the cytoplasm
CC       under non-stressed conditions and ER stress leads to its nuclear
CC       accumulation. {ECO:0000250}.
CC   -!- DOMAIN: The N-terminal region is necessary for its proteasomal
CC       degradation, transcriptional activity and interaction with EP300/P300.
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitinated, leading to its degradation by the proteasome.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylation at serine residues by MAPK14 enhances its
CC       transcriptional activation activity while phosphorylation at serine
CC       residues by CK2 inhibits its transcriptional activation activity.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the bZIP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U36994; AAA87944.1; -; mRNA.
DR   AlphaFoldDB; Q62857; -.
DR   SMR; Q62857; -.
DR   ComplexPortal; CPX-60; bZIP transcription factor complex, Cebpa-Ddit3.
DR   ComplexPortal; CPX-62; bZIP transcription factor complex, Cebpb-Ddit3.
DR   IntAct; Q62857; 3.
DR   STRING; 10116.ENSRNOP00000071840; -.
DR   ChEMBL; CHEMBL3797018; -.
DR   PhosphoSitePlus; Q62857; -.
DR   PaxDb; 10116-ENSRNOP00000008941; -.
DR   UCSC; RGD:62391; rat.
DR   AGR; RGD:62391; -.
DR   RGD; 62391; Ddit3.
DR   eggNOG; KOG3119; Eukaryota.
DR   InParanoid; Q62857; -.
DR   PhylomeDB; Q62857; -.
DR   PRO; PR:Q62857; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:1990622; C:CHOP-ATF3 complex; ISO:RGD.
DR   GO; GO:1990617; C:CHOP-ATF4 complex; ISO:RGD.
DR   GO; GO:0036488; C:CHOP-C/EBP complex; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005770; C:late endosome; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0032993; C:protein-DNA complex; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0008140; F:cAMP response element binding protein binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0043522; F:leucine zipper domain binding; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:RGD.
DR   GO; GO:0140537; F:transcription regulator activator activity; ISO:RGD.
DR   GO; GO:0140416; F:transcription regulator inhibitor activity; ISO:RGD.
DR   GO; GO:0009948; P:anterior/posterior axis specification; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISS:UniProtKB.
DR   GO; GO:0060840; P:artery development; ISO:RGD.
DR   GO; GO:0001955; P:blood vessel maturation; ISS:UniProtKB.
DR   GO; GO:0045454; P:cell redox homeostasis; ISO:RGD.
DR   GO; GO:0071287; P:cellular response to manganese ion; IEP:ParkinsonsUK-UCL.
DR   GO; GO:0048568; P:embryonic organ development; IEP:RGD.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; ISS:UniProtKB.
DR   GO; GO:0006983; P:ER overload response; IMP:RGD.
DR   GO; GO:0072655; P:establishment of protein localization to mitochondrion; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0140467; P:integrated stress response signaling; ISO:RGD.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:1990442; P:intrinsic apoptotic signaling pathway in response to nitrosative stress; ISO:RGD.
DR   GO; GO:0001554; P:luteolysis; IEP:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:2000016; P:negative regulation of determination of dorsal identity; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; ISO:RGD.
DR   GO; GO:0032700; P:negative regulation of interleukin-17 production; ISO:RGD.
DR   GO; GO:0032713; P:negative regulation of interleukin-4 production; ISO:RGD.
DR   GO; GO:0045662; P:negative regulation of myoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0051898; P:negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0032689; P:negative regulation of type II interferon production; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0034263; P:positive regulation of autophagy in response to ER overload; IMP:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; ISS:UniProtKB.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; ISS:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0010506; P:regulation of autophagy; IMP:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:UniProtKB.
DR   GO; GO:0001975; P:response to amphetamine; IEP:RGD.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:1904373; P:response to kainic acid; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IEP:RGD.
DR   GO; GO:0036119; P:response to platelet-derived growth factor; ISO:RGD.
DR   GO; GO:0042594; P:response to starvation; ISS:UniProtKB.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0006986; P:response to unfolded protein; ISS:UniProtKB.
DR   GO; GO:0009611; P:response to wounding; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; ISO:RGD.
DR   GO; GO:1904738; P:vascular associated smooth muscle cell migration; ISO:RGD.
DR   GO; GO:1990874; P:vascular associated smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.5.170; -; 1.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR046347; bZIP_sf.
DR   InterPro; IPR016670; DNA_damage_induc_transcript_3.
DR   PANTHER; PTHR16833; DNA DAMAGE-INDUCIBLE TRANSCRIPT 3 DDIT3; 1.
DR   PANTHER; PTHR16833:SF0; DNA DAMAGE-INDUCIBLE TRANSCRIPT 3 PROTEIN; 1.
DR   PIRSF; PIRSF016571; C/EBPzeta_CHOP_DDIT3; 1.
DR   SMART; SM00338; BRLZ; 1.
DR   SUPFAM; SSF57959; Leucine zipper domain; 1.
DR   PROSITE; PS50217; BZIP; 1.
PE   2: Evidence at transcript level;
KW   Activator; Apoptosis; Cell cycle; Cytoplasm; DNA-binding; Growth arrest;
KW   Nucleus; Phosphoprotein; Reference proteome; Repressor; Stress response;
KW   Transcription; Transcription regulation; Ubl conjugation;
KW   Unfolded protein response; Wnt signaling pathway.
FT   CHAIN           1..168
FT                   /note="DNA damage-inducible transcript 3 protein"
FT                   /id="PRO_0000076644"
FT   DOMAIN          98..161
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          10..26
FT                   /note="N-terminal"
FT                   /evidence="ECO:0000250"
FT   REGION          10..18
FT                   /note="Interaction with TRIB3"
FT                   /evidence="ECO:0000250"
FT   REGION          34..130
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          100..129
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          133..147
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   COMPBIAS        34..58
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        69..88
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        115..130
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         14
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000250|UniProtKB:P35639"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000250|UniProtKB:P35639"
FT   MOD_RES         30
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000250|UniProtKB:P35639"
FT   MOD_RES         31
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000250|UniProtKB:P35639"
FT   MOD_RES         78
FT                   /note="Phosphoserine; by MAPK14"
FT                   /evidence="ECO:0000250|UniProtKB:P35639"
FT   MOD_RES         81
FT                   /note="Phosphoserine; by MAPK14"
FT                   /evidence="ECO:0000250|UniProtKB:P35639"
SQ   SEQUENCE   168 AA;  19013 MW;  251716CD712BA6E1 CRC64;
     MAAESLPFAF ETVSSWELEA WYEDLQEVLS SDEIGGTYIS SPGNEEEESK TFTTLDPASL
     AWLTEEPGPA EVTSTSQSPR SPDSSQSSMA QEEEEEDQGR TRKRKQSGQC AARAGKQRMK
     EKEQENERKV AQLAEENERL KLEIERLTRE VETTRRALID RMVSLHQA
//
